Correlation Between Tarsus Pharmaceuticals and Arrow Financial

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Arrow Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Arrow Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Arrow Financial, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Arrow Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Arrow Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Arrow Financial.

Diversification Opportunities for Tarsus Pharmaceuticals and Arrow Financial

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Tarsus and Arrow is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Arrow Financial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrow Financial and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Arrow Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrow Financial has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Arrow Financial go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Arrow Financial

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.71 times more return on investment than Arrow Financial. However, Tarsus Pharmaceuticals is 1.71 times more volatile than Arrow Financial. It trades about 0.09 of its potential returns per unit of risk. Arrow Financial is currently generating about 0.02 per unit of risk. If you would invest  1,451  in Tarsus Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  3,763  from holding Tarsus Pharmaceuticals or generate 259.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  Arrow Financial

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Arrow Financial 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Arrow Financial are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Arrow Financial may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Tarsus Pharmaceuticals and Arrow Financial Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Arrow Financial

The main advantage of trading using opposite Tarsus Pharmaceuticals and Arrow Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Arrow Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrow Financial will offset losses from the drop in Arrow Financial's long position.
The idea behind Tarsus Pharmaceuticals and Arrow Financial pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities